Skip to main content
Year archive

BIOTRON LIMITED — 2022 filings

All 38 regulatory filings released by BIOTRON LIMITED (BIT) in 2022, sourced directly from the official regulator.

38 Filings
2022 Period
2022 filings (38)
Filing Released Lang
Change of Director's Interest Notice 9 pages 235.5KB
Regulatory Filings
2022-11-28 English
Notification of cessation of securities - BIT 4 pages 24.2KB
Regulatory Filings
2022-11-27 English
Application for quotation of securities - BIT 8 pages 32.4KB
Regulatory Filings
2022-11-24 English
Application for quotation of securities 20 pages 330.7KB
Regulatory Filings
2022-11-24 English
Listed Options Information 2 pages 93.2KB
Regulatory Filings
2022-11-24 English
Cleansing Notice 1 page 97.1KB
Regulatory Filings
2022-11-24 English
Supplementary Prospectus 6 pages 144.6KB
Regulatory Filings
2022-11-23 English
Rights Issue Closed 2 pages 179.5KB
Regulatory Filings
2022-11-23 English
Proposed issue of securities - BIT 6 pages 30.5KB
Regulatory Filings
2022-11-23 English
Cancel - Proposed issue of securities - BIT 10 pages 41.9KB
Regulatory Filings
2022-11-21 English
Appendix 3B 53 pages 667.5KB
Regulatory Filings
2022-11-20 English
$1.43M R&D rebate received 2 pages 153.0KB
Regulatory Filings
2022-11-17 English
Chairman's Address and Presentation to AGM 13 pages 383.6KB
Regulatory Filings
2022-11-15 English
Results of Annual General Meeting 2 pages 178.4KB
Regulatory Filings
2022-11-15 English
Presentation to Investors 13 pages 410.2KB
Regulatory Filings
2022-11-10 English
Clarification of Fractional Entitlements 1 page 116
Regulatory Filings
2022-11-06 English
Letter to Shareholders 3 pages 379.9KB
Regulatory Filings
2022-10-30 English
Commencement of Rights Trading - BITRC 2 pages 132.5KB
Regulatory Filings
2022-10-30 English
Proposed issue of securities - BIT 10 pages 42.3KB
Regulatory Filings
2022-10-26 English
Renounceable Issue 3 pages 196.0KB
Regulatory Filings
2022-10-26 English
Prospectus 56 pages 731.2KB
Regulatory Filings
2022-10-26 English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 365.1KB
Regulatory Filings
2022-10-23 English
Annual Report and Notice of Annual General Meeting 57 pages 3.2MB
Regulatory Filings
2022-10-13 English
Second BIT225 Phase 2 HIV-1 Clinical Trial Fully Recruited 2 pages 186.5KB
Regulatory Filings
2022-10-03 English
Bit225 Covid-19 Human Study Commenced 2 pages 175.8KB
Regulatory Filings
2022-09-13 English
BIT225 Phase 2 HIV-1 Clinical Trial Fully Recruited 2 pages 158.9KB
Regulatory Filings
2022-08-22 English
Full Year Statutory Accounts and Appendix 4E 50 pages 690.0KB
Regulatory Filings
2022-08-18 English
Appendix 4G and Corporate Governance Statement 23 pages 642.7KB
Regulatory Filings
2022-08-18 English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 1.1MB
Regulatory Filings
2022-07-27 English
POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM 2 pages 134.8KB
Regulatory Filings
2022-05-29 English
BIT225 EFFECTIVE AGAINST ESTABLISHED SARS-CoV-2 IN ANIMALS 6 pages 362.2KB
Regulatory Filings
2022-05-01 English
Quarterly Activities Report 3 pages 141.7KB
Regulatory Filings
2022-04-25 English
Quarterly Cash Flow Report Appendix 4C 5 pages 258.0KB
Regulatory Filings
2022-04-25 English
$1.56M R&D Rebate Received 2 pages 152.8KB
Regulatory Filings
2022-04-04 English
BIT225 Effectiveness Against COVID-19 in Animals 4 pages 220.5KB
Regulatory Filings
2022-03-16 English
Half Yearly Report and Accounts 21 pages 641.9KB
Regulatory Filings
2022-02-22 English
Quarterly Appendix 4C Cash Flow Report 5 pages 256.5KB
Regulatory Filings
2022-01-27 English
Quarterly Activities/Appendix 4C Cash Flow Report 3 pages 140.2KB
Regulatory Filings
2022-01-27 English